Skip to content
Evonik
-
Evonik invests US$100M to expand Indiana API manufacturing as demand for US CDMO services grows
Evonik will use the funding to upgrade major production assets, including large reactors and other critical processing systems.
-
Evonik invests US$93.5M to increase fermentation capacity in Slovakia for pharmaceutical manufacturing
The Slovenská Ľupča site will support Evonik’s contract development and manufacturing organization (CDMO) services within its drug substance business.